Millennium Management LLC Grows Stock Holdings in Sensus Healthcare, Inc. (NASDAQ:SRTS)

Millennium Management LLC grew its holdings in Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) by 256.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 85,329 shares of the company's stock after purchasing an additional 61,403 shares during the quarter. Millennium Management LLC owned about 0.52% of Sensus Healthcare worth $590,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. JPMorgan Chase & Co. acquired a new stake in shares of Sensus Healthcare during the 4th quarter worth approximately $27,000. Barclays PLC acquired a new stake in shares of Sensus Healthcare during the 4th quarter worth approximately $35,000. BNP Paribas Financial Markets acquired a new stake in shares of Sensus Healthcare during the 4th quarter worth approximately $47,000. IFP Advisors Inc acquired a new stake in shares of Sensus Healthcare during the 4th quarter worth approximately $95,000. Finally, NewEdge Advisors LLC acquired a new stake in shares of Sensus Healthcare during the 4th quarter worth approximately $109,000. 25.30% of the stock is owned by hedge funds and other institutional investors.

Sensus Healthcare Price Performance

Shares of Sensus Healthcare stock opened at $4.92 on Friday. The business has a 50-day moving average of $4.63 and a 200-day moving average of $5.87. The company has a market capitalization of $80.91 million, a PE ratio of 12.30 and a beta of 1.32. Sensus Healthcare, Inc. has a 1-year low of $4.01 and a 1-year high of $9.33.

Sensus Healthcare (NASDAQ:SRTS - Get Free Report) last issued its quarterly earnings results on Thursday, May 15th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of $0.04 by ($0.20). Sensus Healthcare had a return on equity of 12.60% and a net margin of 15.90%. The company had revenue of $8.34 million for the quarter, compared to the consensus estimate of $7.23 million. On average, equities analysts expect that Sensus Healthcare, Inc. will post 0.32 earnings per share for the current fiscal year.

Analysts Set New Price Targets

SRTS has been the subject of a number of research reports. Lake Street Capital dropped their price objective on Sensus Healthcare from $18.00 to $13.00 and set a "buy" rating for the company in a research note on Tuesday, March 11th. Wall Street Zen downgraded Sensus Healthcare from a "hold" rating to a "sell" rating in a report on Thursday, May 22nd. HC Wainwright reaffirmed a "buy" rating and set a $12.00 price target on shares of Sensus Healthcare in a report on Friday, April 4th. Finally, Maxim Group reduced their target price on Sensus Healthcare from $14.00 to $10.00 and set a "buy" rating for the company in a report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, three have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $11.67.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.

Want to see what other hedge funds are holding SRTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.